Gut microbiome, short-chain fatty acids, alpha-synuclein, neuroinflammation, and ROS/RNS: Relevance to Parkinson's disease and therapeutic implications-Reference-Cited by-同舟云学术

Gut microbiome, short-chain fatty acids, alpha-synuclein, neuroinflammation, and ROS/RNS: Relevance to Parkinson's disease and therapeutic implications

Published:2024-05 Issue: Volume:71 Page:103092
ISSN:2213-2317
Container-title:Redox Biology
language:en
Short-container-title:Redox Biology

Author:

Kalyanaraman Balaraman^ORCID,Cheng Gang,Hardy Micael

Publisher

Elsevier BV

Reference117 articles.

1. Gut microbiota: a novel therapeutic target for Parkinson's disease;Zhu;Front. Immunol.,2022

2. Parkinson's Disease and the Gut-Brain Axis: Unraveling Signaling Pathways and the Connection between Parkinson's Disease and Gut Bacteria-Related Disorders, Independently Published;Branch,2023

3. Initiation and propagation of α-synuclein aggregation in the nervous system;Hijaz;Mol. Neurodegener.,2020

4. The microbiota-gut-brain Axis;Cryan;Physiol. Rev.,2019

5. Parkinson's disease patients' short chain fatty acids production capacity after in vitro fecal fiber fermentation;Baert;NPJ Parkinsons Dis,2021

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The role of gut-derived short-chain fatty acids in Parkinson's disease;Neurogenetics;2024-09-13

2. Pharmacological mechanisms of puerarin in the treatment of Parkinson's disease: An overview;Biomedicine & Pharmacotherapy;2024-08

3. Short-chain fatty acids suppresses astrocyte activation by amplifying Trp-AhR-AQP4 signaling in experimental autoimmune encephalomyelitis mice;Cellular and Molecular Life Sciences;2024-07-08

4. Gut–Brain Axis in Focus: Polyphenols, Microbiota, and Their Influence on α-Synuclein in Parkinson’s Disease;Nutrients;2024-06-27

5. Interaction between α-Synuclein and Bioactive Lipids: Neurodegeneration, Disease Biomarkers and Emerging Therapies;Metabolites;2024-06-22